Wednesday, November 29, 2023

The CRISPR Era Is Here | The Pandemic Disrupted Adolescent Brain Development | 7 Rules for Job Interview Questions That Result in Great Hires | See The Luxury Homes CEOs And Founders Have Put On The Market This Year

View online | Unsubscribe (one-click).
For inquiries/unsubscribe issues, Contact Us


Learn more about Jeeng

Learn more about Jeeng

Learn more about Jeeng

Learn more about Jeeng
Learn more about Jeeng













You Might Like
Learn more about RevenueStripe...

Learn more about RevenueStripe...


Learn more about RevenueStripe...

Learn more about RevenueStripe...

Learn more about RevenueStripe...

Learn more about RevenueStripe...

Learn more about RevenueStripe...













Want to accelerate software development at your company? See how we can help.
Want to accelerate software development at your company? See how we can help.

The CRISPR Era Is Here - The Atlantic   

When Victoria Gray was still a baby, she started howling so inconsolably during a bath that she was rushed to the emergency room. The diagnosis was sickle-cell disease, a genetic condition that causes bouts of excruciating pain—“worse than a broken leg, worse than childbirth,” one doctor told me. Like lightning crackling in her body is how Gray, now 38, has described the pain. For most of her life, she lived in fear that it could strike at any moment, forcing her to drop everything to rush, once again, to the hospital.

After a particularly long and debilitating hospitalization in college, Gray was so weak that she had to relearn how to stand, how to use a spoon. She dropped out of school. She gave up on her dream of becoming a nurse.

Four years ago, she joined a groundbreaking clinical trial that would change her life. She became the first sickle-cell patient to be treated with the gene-editing technology CRISPR—and one of the first humans to be treated with CRISPR, period. CRISPR at that point had been hugely hyped, but had largely been used only to tinker with cells in a lab. When Gray got her experimental infusion, scientists did not know whether it would cure her disease or go terribly awry inside her. The therapy worked—better than anyone dared to hope. With her gene-edited cells, Gray now lives virtually symptom-free. Twenty-nine of 30 eligible patients in the trial went from multiple pain crises every year to zero in 12 months following treatment.

Continued here


Learn more about Jeeng

Learn more about Jeeng

Learn more about Jeeng

Learn more about Jeeng
Learn more about Jeeng













You Might Like
Learn more about RevenueStripe...

Learn more about RevenueStripe...


Learn more about RevenueStripe...

Learn more about RevenueStripe...

Learn more about RevenueStripe...

Learn more about RevenueStripe...

Learn more about RevenueStripe...













Want to accelerate software development at your company? See how we can help.
Want to accelerate software development at your company? See how we can help.


Learn more about Jeeng

Learn more about Jeeng

Learn more about Jeeng

Learn more about Jeeng
Learn more about Jeeng













You Might Like
Learn more about RevenueStripe...

Learn more about RevenueStripe...


Learn more about RevenueStripe...

Learn more about RevenueStripe...

Learn more about RevenueStripe...

Learn more about RevenueStripe...

Learn more about RevenueStripe...




Want to accelerate software development at your company? See how we can help.



Learn more about Jeeng

Learn more about Jeeng

Learn more about Jeeng

Learn more about Jeeng
Learn more about Jeeng













You Might Like
Learn more about RevenueStripe...

Learn more about RevenueStripe...


Learn more about RevenueStripe...

Learn more about RevenueStripe...

Learn more about RevenueStripe...

Learn more about RevenueStripe...

Learn more about RevenueStripe...















Learn more about Jeeng

Learn more about Jeeng

Learn more about Jeeng

Learn more about Jeeng
Learn more about Jeeng













You Might Like
Learn more about RevenueStripe...

Learn more about RevenueStripe...


Learn more about RevenueStripe...

Learn more about RevenueStripe...

Learn more about RevenueStripe...

Learn more about RevenueStripe...

Learn more about RevenueStripe...













You are receiving this mailer as a TradeBriefs subscriber.
We fight fake/biased news through human curation & independent editorials.
Your support of ads like these makes it possible. Alternatively, get TradeBriefs Premium (ad-free) for only $2/month
If you still wish to unsubscribe, you can unsubscribe from all our emails here
Our address is 309 Town Center 1, Andheri Kurla Road, Andheri East, Mumbai 400059 - 433006120

No comments:

Post a Comment